Since 1967, Balchem Corporation (NASDAQ: BCPC) has developed and manufactured specialty ingredients for the nutrition, food, sterilization, and energy markets around the world. Together with our employees, customers, and shareholders, we are committed to delivering products that improve all aspects of life.

We welcome you to explore our Investor Relations portal, where you can get to know our goals and strategies to support your investment decision and increase long-term shareholder value.

BCPC close on 2020-04-02 : $95.33 +2.24 (+2.41%)
 

News, Events, Presentations

Current Financials: Updated: February 21, 2020

• Fourth quarter net sales of $166.5 million, an increase of $3.0 million, or 1.8%, compared to the prior year quarter.
• Year over year quarterly sales growth in three of the four segments, with all-time record sales in Human Nutrition and Health and Animal Nutrition and Health, and record fourth quarter sales in Specialty Products.
• Fourth quarter GAAP net earnings of $20.4 million were slightly higher than the prior year. These net earnings resulted in GAAP earnings per share of $0.63.
• Quarterly adjusted net earnings of $28.4 million increased $3.3 million or 12.9% from the prior year, resulting in adjusted earnings per share of $0.88.
• Fourth quarter adjusted EBITDA was $40.0 million, an increase of $0.4 million, or 1.0%, from the prior year.
• Quarterly cash flows from operations were $33.0 million for the fourth quarter 2019 with quarterly free cash flow of $26.3 million.

Full Year 2019 Financial Highlights

• Full year net sales of $643.7 million were slightly higher than the prior year.
• Year over year sales growth in three of the four segments, with all-time record sales in Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products, offset by reduced sales in Industrial Products.
• Full year GAAP net earnings were $79.7 million, an increase of $1.1 million, or 1.4% from the prior year. These net earnings resulted in GAAP earnings per share of $2.45.
• Full year adjusted net earnings of $103.7 million increased $5.9 million or 6.1% from the prior year, resulting in adjusted earnings per share of $3.19.
• Full year adjusted EBITDA was $160.0 million, an increase of $0.7 million, or 0.5%, from the prior year.
• Full year cash flows from operations were $124.5 million for 2019 with full year free cash flow of $96.1 million.

Click here for the detailed Quarterly Report

Click here for the Q4 2019 Investor Presentation

Leadership

Ted Harris

Chairman and Chief Executive Officer

Jim Hyde Bio

Jim Hyde

Senior Vice President and General Manager, Human Nutrition & Health

Martin Bengtsson

Chief Financial Officer

Jonathan Griffin

Vice President and General Manager, Animal Nutrition & Health

Mark Stach

General Counsel

Job van Gunsteren

Vice President and General Manager, Specialty Products

Scott Mason

Vice President and General Manager, Industrial Products/ VP MFG & Supply Chain

Board of Directors

Ted Harris

Chairman and Chief Executive Officer,
Balchem Corporation

John Televantos, PhD

Partner,
Arsenal Capital Partners, Inc.

Perry W. Premdas

Former Chief Financial Officer,
Celanese AG.

Paul D. Coombs

Former EVP and Chief Operating Officer,
Tetra Technologies, Inc.

David B. Fischer

Former President and Chief Executive Officer,
Greif, Inc.

Joyce Lee

President, North America, Bayer Animal Health,
Bayer

Matthew Wineinger

President and Chief Executive Officer,
United Sugars Corporation

Daniel E. Knutson

Former EVP and Chief Financial Officer,
Land O’Lakes

Let us know how we can help you. Contact